Vincent Roh
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- CRISPR and Genetic Engineering 2
- FOXO transcription factor regulation 1
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Stephan A. Vorburger (5 shared papers)Deborah Stroka (4 shared papers)Daniel Candinas (4 shared papers)Alexander Laemmle (3 shared papers)Adrian Keogh (2 shared papers)Mario P. Tschan (2 shared papers)Karen G. Montgomery (2 shared papers)Christian Simon (5 shared papers)
- Journals
- PLoS ONE (2 papers)EMBO Molecular Medicine (2 papers)Cancer Gene Therapy (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Vincent Roh
15 papers receiving 425 citations
Peers
Comparison fields: 5 of 61
- Geriatrics and Gerontology 63
- Cancer Research 90
- Oncology 128
- Molecular Biology 220
- Immunology 63
Countries citing papers authored by Vincent Roh
This map shows the geographic impact of Vincent Roh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Roh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Roh more than expected).
Fields of papers citing papers by Vincent Roh
This network shows the impact of papers produced by Vincent Roh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Roh. The network helps show where Vincent Roh may publish in the future.
Co-authors
The 25 scholars most cited alongside Vincent Roh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 126 | |
| 2 | 2012 | 58 | |
| 3 | 2007 | 40 | |
| 4 | 2018 | 29 | |
| 5 | 2018 | 29 | |
| 6 | 2021 | 27 | |
| 7 | 2009 | 24 | |
| 8 | 2023 | 21 | |
| 9 | 2013 | 19 | |
| 10 | 2009 | 17 | |
| 11 | 2008 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2024 | 6 | |
| 15 | 2025 | 3 |
About Vincent Roh
Vincent Roh is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Cancer Research, having authored 15 papers that have together received 429 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Ferroptosis and cancer prognosis (1 paper), Head and Neck Cancer Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Geriatrics and Gerontology (63 citations), Cancer Research (90 citations), Oncology (128 citations), Molecular Biology (220 citations) and Immunology (63 citations). Vincent Roh has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Stephan A. Vorburger, Deborah Stroka, Daniel Candinas, Alexander Laemmle, Adrian Keogh, Mario P. Tschan, Karen G. Montgomery, Christian Simon, Lauren Hare and Genrich V. Tolstonog. Their work appears in journals such as PLoS ONE, EMBO Molecular Medicine, Cancer Gene Therapy, Journal for ImmunoTherapy of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.